Endocrinology Practice Questions

Q: Calcitonin is released by:

Parafollicular cells of thyroid. **Explanation:** **Calcitonin** is a 32-amino acid peptide hormone primarily involved in calcium homeostasis. It is synthesized and secreted by the **Parafollicular cells (also known as C-cells)** of the thyroid gland. These cells are neuroendocrine in origin (derived from the neural crest) and are located in the connective tissue between the thyroid follicles. Calcitonin acts to lower plasma calcium levels by inhibiting osteoclast activity and decreasing renal calcium reabsorption, effectively acting as a physiological antagonist to Parathyroid Hormone (PTH). **Analysis of Incorrect Options:** * **B. Chief cells of thyroid:** This is a distractor. Chief cells are found in the **Parathyroid glands**, where they secrete Parathyroid Hormone (PTH), not in the thyroid gland. * **C. Granular cells of adrenal gland:** There are no specific "granular cells" defined as a major secretory unit in the adrenal gland. The adrenal medulla contains Chromaffin cells which secrete catecholamines. * **D. Stratum fasciculata of adrenal gland:** This is the middle layer of the adrenal cortex responsible for secreting **Glucocorticoids** (primarily Cortisol), not calcitonin. **High-Yield Clinical Pearls for NEET-PG:** * **Stimulus for Release:** The primary stimulus for calcitonin secretion is **hypercalcemia**. * **Tumor Marker:** Calcitonin serves as a critical tumor marker for **Medullary Thyroid Carcinoma (MTC)**, which arises from the Parafollicular C-cells. * **Therapeutic Use:** Exogenous calcitonin (often salmon calcitonin) is used clinically to treat Paget’s disease of the bone and severe hypercalcemia. * **Developmental Origin:** While thyroid follicular cells arise from the endoderm (thyroglossal duct), the Parafollicular C-cells originate from the **ultimobranchial body** (derived from the 4th/5th pharyngeal pouches).

Q: Insulin acts by stimulation of which type of receptor?

Enzymatic receptor. **Explanation:** The insulin receptor belongs to the **Enzymatic receptor** family, specifically the **Receptor Tyrosine Kinase (RTK)** class. It is a heterotetramer consisting of two extracellular alpha-subunits (binding site) and two transmembrane beta-subunits. When insulin binds to the alpha-subunits, it triggers autophosphorylation of the beta-subunits. This activates the intrinsic tyrosine kinase activity, which then phosphorylates **Insulin Receptor Substrates (IRS)**, leading to downstream metabolic effects like glucose uptake via GLUT-4 translocation. **Analysis of Options:** * **A. Ionotropic receptors:** These are ligand-gated ion channels (e.g., Nicotinic ACh receptors) that change membrane potential. Insulin does not directly open an ion channel. * **C. Metabotropic receptors:** These are G-Protein Coupled Receptors (GPCRs) that act via second messengers like cAMP or IP3/DAG (e.g., Glucagon, Epinephrine). Insulin does not utilize G-proteins. * **D. Nuclear receptors:** These are intracellular receptors for lipid-soluble hormones (e.g., Steroids, Thyroid hormone) that act as transcription factors. Insulin is a peptide hormone and cannot cross the lipid bilayer. **High-Yield Clinical Pearls for NEET-PG:** * **GLUT-4:** The only insulin-dependent glucose transporter, found primarily in skeletal muscle and adipose tissue. * **MAP Kinase Pathway:** Mediates the growth-promoting (mitogenic) effects of insulin. * **PI3-Kinase Pathway:** Mediates the metabolic effects (glucose transport and glycogen synthesis). * **Downregulation:** Chronic hyperinsulinemia (as seen in Type 2 Diabetes) leads to "internalization" of receptors, contributing to insulin resistance.

Q: What is the primary mechanism through which catecholamines stabilize blood glucose concentration in response to hypoglycemia?

Catecholamines stimulate gluconeogenesis in the liver.. **Explanation:** The primary goal of catecholamines (Epinephrine and Norepinephrine) during hypoglycemia is to increase blood glucose levels rapidly. This is achieved through the activation of **$\beta_2$ and $\alpha_1$ receptors** in the liver. **Why Option D is correct:** Catecholamines are potent counter-regulatory hormones. They stimulate **gluconeogenesis** (the synthesis of glucose from non-carbohydrate precursors like lactate and amino acids) and **glycogenolysis** (breakdown of glycogen) in the liver. By increasing the expression of key enzymes like PEPCK (Phosphoenolpyruvate carboxykinase), they ensure a sustained release of glucose into the systemic circulation to protect the brain. **Why other options are incorrect:** * **Option A:** While catecholamines do stimulate glycogen phosphorylase in muscles, **muscle lacks the enzyme Glucose-6-Phosphatase**. Therefore, muscle glycogen is converted to lactate (via glycolysis) rather than free glucose, and cannot directly contribute to blood glucose levels. * **Option B:** Catecholamines **stimulate** liver glycogenolysis; inhibiting it would worsen hypoglycemia. * **Option C:** Catecholamines actually **inhibit insulin release** (via $\alpha_2$ receptors) and stimulate glucagon release (via $\beta_2$ receptors) to prevent further glucose uptake by peripheral tissues. **High-Yield NEET-PG Pearls:** * **Dual Action:** Catecholamines increase glucose **production** (liver) and decrease glucose **utilization** (peripheral tissues like muscle/adipose) to spare glucose for the CNS. * **Receptor Specificity:** Hepatic glucose production is mediated by both $\alpha_1$ and $\beta_2$ receptors, but the **inhibition of insulin** is primarily an **$\alpha_2$ effect**. * **Hierarchy:** In the defense against hypoglycemia, Glucagon is the first line of defense, followed closely by Epinephrine. Cortisol and Growth Hormone act much later.

Q: Which of the following hormones utilizes the JAK-STAT transducer mechanism?

Growth hormone. The **JAK-STAT (Janus Kinase-Signal Transducer and Activator of Transcription)** pathway is a distinct signaling mechanism used by receptors that lack intrinsic tyrosine kinase activity but associate with soluble tyrosine kinases [4]. **1. Why Growth Hormone (GH) is correct:** Growth hormone belongs to the **Cytokine Receptor Superfamily** [3]. When GH binds to its receptor, it induces dimerization, which activates cytoplasmic **JAK2** kinases [1]. These kinases phosphorylate the receptor and **STAT** proteins. The phosphorylated STATs then translocate to the nucleus to regulate gene transcription [5]. Other hormones using this pathway include Prolactin, Erythropoietin, and Leptin [2]. **2. Why the other options are incorrect:** * **Somatostatin:** Acts via **G-Protein Coupled Receptors (GPCR)**, specifically the $G_i$ subtype, which inhibits adenylyl cyclase and decreases cAMP levels. * **Insulin:** Utilizes a **Receptor Tyrosine Kinase (RTK)**. Unlike GH, the insulin receptor has *intrinsic* enzymatic activity (the receptor itself is a kinase) and primarily signals through the IRS-1/PI3K pathway. * **Adenosine:** Acts through **GPCRs** ($A_1, A_2, A_3$ receptors). $A_1$ is $G_i$-coupled (inhibitory), while $A_2$ is $G_s$-coupled (stimulatory). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for JAK-STAT:** "**PIGGLy**" — **P**rolactin, **I**mmunomodulators (Cytokines/Interferons), **G**rowth Hormone, **G**-CSF, **L**eptin/Erythropoietin. * **Laron Dwarfism:** Caused by a mutation in the Growth Hormone receptor, leading to defective JAK-STAT signaling despite high GH levels. * **Tofacitinib:** A JAK inhibitor used clinically in the treatment of Rheumatoid Arthritis [5].

Q: Which of the following directly inhibits insulin secretion?

Alpha2-adrenergic agonist. **Explanation:** The secretion of insulin by pancreatic beta cells is tightly regulated by the autonomic nervous system and various hormones. **1. Why Alpha2-adrenergic agonists are correct:** The sympathetic nervous system has a dual effect on insulin secretion, but the **inhibitory effect mediated by $\alpha_2$-adrenergic receptors** is dominant. When $\alpha_2$ receptors are stimulated (via norepinephrine or agonists), they couple with $G_i$ proteins, leading to a decrease in intracellular cAMP levels. This inhibits the exocytosis of insulin granules. This mechanism is physiologically vital during exercise or stress (the "fight or flight" response) to prevent hypoglycemia while ensuring adequate glucose is available for the brain and muscles. **2. Why the other options are incorrect:** * **B. Beta2-adrenergic agonist:** Stimulation of $\beta_2$ receptors (via $G_s$ proteins) actually **increases** insulin secretion. However, in a systemic sympathetic discharge, the $\alpha_2$ inhibitory effect overrides the $\beta_2$ stimulatory effect. * **C. Cholecystokinin (CCK):** This is a gastrointestinal hormone (incretin-like effect) that **stimulates** insulin secretion in response to food intake. * **D. Glucagon:** Glucagon has a direct paracrine effect on adjacent beta cells to **stimulate** insulin secretion, ensuring that the glucose released by the liver (via glycogenolysis) can be utilized by peripheral tissues. **High-Yield Clinical Pearls for NEET-PG:** * **Dominant Control:** While Parasympathetic (Vagus/M3) and $\beta_2$ stimulation increase insulin, **$\alpha_2$ stimulation is the most potent physiological inhibitor.** * **Somatostatin:** Produced by Delta ($\delta$) cells, it is a potent paracrine inhibitor of both insulin and glucagon. * **Incretin Effect:** Oral glucose causes a much higher insulin spike than IV glucose due to hormones like GLP-1 and GIP.

Q: Which of the following hormones increases with age?

Luteinizing Hormone (LH). **Explanation:** The correct answer is **Luteinizing Hormone (LH)**. This phenomenon is primarily driven by the age-related decline in gonadal function, known as the "somatopause" in men and menopause in women. **1. Why LH increases:** As individuals age, there is a progressive decrease in the production of sex steroids (Estrogen/Progesterone in females and Testosterone in males) due to primary gonadal failure. This loss of negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis leads to a compensatory increase in the secretion of **Gonadotropins**, specifically **LH and FSH**. In post-menopausal women, FSH typically rises more significantly than LH, but both remain elevated compared to reproductive years. **2. Why other options are incorrect:** * **Growth Hormone (GH):** GH secretion declines significantly with age (approximately 14% per decade after age 30), contributing to reduced muscle mass and increased adiposity. * **Prolactin:** Levels generally remain stable or slightly decrease with age, particularly in post-menopausal women due to the lack of estrogenic stimulation on lactotrophs. * **Insulin:** While insulin *resistance* often increases with age, the actual basal secretion of insulin tends to decline due to progressive $\beta$-cell dysfunction and reduced pancreatic mass. **High-Yield Clinical Pearls for NEET-PG:** * **Hormones that Decrease with Age:** GH, Melatonin, DHEA (Dehydroepiandrosterone), Aldosterone, and Testosterone. * **Hormones that Increase with Age:** LH, FSH, PTH (Parathyroid Hormone), Norepinephrine, and Cortisol (slight increase in evening levels). * **Hormones that remain Unchanged:** Thyroid hormones (T3/T4) usually remain in the normal range, though TSH may show a slight upward shift in the elderly.

Question 1

Calcitonin is released by:

Accepted Answer

Parafollicular cells of thyroid

Answer

Chief cells of thyroid

Answer

Granular cells of adrenal gland

Answer

Stratum fasciculata of adrenal gland

Question 2

Which of the following is NOT an action of calcitriol?

Accepted Answer

Calcitriol increases the excretion of calcium and phosphate through the kidney.

Answer

Calcitriol increases the intestinal absorption of calcium.

Answer

Calcitriol stimulates calcium uptake for deposition as calcium phosphate in the osteoblasts of bone.

Answer

Calcitriol's action is similar to steroid hormones.

Question 3

Glucose-dependent release of insulin is mediated by which mechanism?

Accepted Answer

Cyclic AMP

Answer

Carrier's modulators

Answer

Receptor phosphorylation

Answer

ATP-dependent K+ channel

Question 4

Insulin acts by stimulation of which type of receptor?

Accepted Answer

Enzymatic receptor

Answer

Ionotropic receptor

Answer

Metabotropic receptor

Answer

Nuclear receptor

Question 5

In a transection between the hypothalamus and the anterior pituitary, the production of which hormone remains unaffected?

Accepted Answer

Oxytocin

Answer

Testosterone

Answer

Thyroxine

Answer

Cortisol

Question 6

What is the primary mechanism through which catecholamines stabilize blood glucose concentration in response to hypoglycemia?

Accepted Answer

Catecholamines stimulate gluconeogenesis in the liver.

Answer

Catecholamines stimulate glycogen phosphorylase to release glucose from muscle.

Answer

Catecholamines inhibit glycogenolysis in the liver.

Answer

Catecholamines stimulate the release of insulin from the pancreas.

Question 7

Which of the following most accurately describes the transmembrane signaling process involved in steroid hormone action?

Accepted Answer

Diffusion across the membrane and binding to an intracellular receptor

Answer

Action on a membrane-spanning tyrosine kinase

Answer

Action of a G protein, which activates or inhibits adenylyl cyclase

Answer

Opening of transmembrane ion channels

Question 8

Which of the following hormones utilizes the JAK-STAT transducer mechanism?

Accepted Answer

Growth hormone

Answer

Somatostatin

Answer

Insulin

Answer

Adenosine

Question 9

Which of the following directly inhibits insulin secretion?

Accepted Answer

Alpha2-adrenergic agonist

Answer

Beta2-adrenergic agonist

Answer

Cholecystokinin

Answer

Glucagon

Question 10

Which of the following hormones increases with age?

Accepted Answer

Luteinizing Hormone (LH)

Answer

Growth Hormone (GH)

Answer

Prolactin

Answer

Insulin

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?